SCHEMBL5380640

SCHEMBL5380640

Cc1ccc(-c2nnc(-c3ccc(NS(=O)(=O)c4ccc(Cl)c(C(=O)O)c4)cc3)o2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.57
KMT2A Q03164 6/20 0.57
ALDH1A1 P00352 4/20 0.53
HPGD P15428 3/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
LMNA P02545 3/20 0.52
TP53 P04637 2/20 0.52
HTT P42858 2/20 0.52
MAPK1 P28482 1/20 0.52
MAPT P10636 4/20 0.50
PTPN2 P17706 3/20 0.50
PTPN1 P18031 3/20 0.50
PTPN5 P54829 3/20 0.50
GAA P10253 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALOX12 P18054 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RECQL P46063 1/20 0.49
POLB P06746 2/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376825 0.84 PTPN2 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL5376622 0.79 PABPC1 (0.57) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL5377279 0.78 PTPN1 (0.79) MEN1KMT2AHPGDMAPTPTPN2
SCHEMBL5501882 0.78 POLB (0.70) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL5426560 0.77 MEN1 (0.74) MEN1KMT2AALDH1A1LMNATP53
SCHEMBL14309048 0.77 KMT2A (0.66) MEN1KMT2AALDH1A1LMNATP53
SCHEMBL5376836 0.77 PTPN2 (0.69) TP53PTPN2PTPN1PTPN5POLB
SCHEMBL5382225 0.77 MAPT (0.71) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL5376808 0.77 POLB (0.56) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL5376340 0.76 CYP3A4 (0.65) MEN1KMT2ALMNATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885ALDH1A1 2956/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD MEN1 4861/4885KMT2A 3601/4885ALDH1A1 2752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.